Dr. Angelo E. Gousse, MD

Dr. Gousse practices at Aventura Hospital & Medical Center in Miami, Florida.

Dr. Gousse's NPI, 1821028259, was assigned on July 3, 2006. Dr. Gousse graduated from Yale School of Medicine in 1990. Dr. Gousse holds Florida license ME0069645.

Dr. Gousse's primary practice is Aventura Hospital & Medical Center, at 21150 Biscayne Blvd, Miami, FL 33180 in Miami-Dade County. The practice phone is (810) 931-7115.

Dr. Gousse's primary practice is Aventura Hospital & Medical Center in Miami, Florida. Dr. Gousse is also affiliated with HCA Florida JFK Hospital. The medical group on file is Gousse Urology. Dmand AI also links Dr. Gousse to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gousse practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gousse's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gousse is board certified in female pelvic medicine and reconstructive surgery by the American Board of Urology. Dmand AI has Dr. Gousse's licenses on file in 2 states: Florida and California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney stone disease, pelvic prolapse, prostate inflammation or infection and urinary endoscopy among the conditions Dr. Gousse treats.

CMS data shows 1,985 Medicare services from Dr. Gousse across 6 procedure codes in 2024, for 268 Medicare patients. Medicare paid $92,613 for them. Every service was in an office.

CMS counts 268 Medicare patients who saw Dr. Gousse in 2026. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gousse's median patient age at 67, with 17% women.

In 2026, Dr. Gousse wrote 2,005 Medicare Part D claims for 774 patients. 82% of them were for generic drugs. CMS names the drug for 1,896 of them, across 18 drugs with 11 or more claims each, at $265,995 in total drug cost. In 2023, CMS named 3,321 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gousse for performance year 2026, reported individually. Dr. Gousse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gousse as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 60 papers to Dr. Gousse, published from 2005 to 2020. 2008 was the busiest year, with 2. The most frequent topics are Urinary Incontinence, Urinary Incontinence, Stress and Urodynamics. Dr. Gousse has published most often in J Urol. Dr. Gousse's most frequent co-authors are Daniel Joseph Caruso, MD, Prashanth Kanagarajah, MD and Brian Louis Cohen, MD.

Dmand AI links Dr. Gousse to 1 clinical trial. Conditions studied include Spasm and Muscle Spasticity.

CMS Open Payments shows 333 general payments to Dr. Gousse from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Allergan Inc. paid the most, $48,464.

Dmand AI lists 3 awards for Dr. Gousse, most recently Regional Top Doctor in 2014.

Dr. Gousse graduated from Yale School of Medicine in 1990.

Dr. Gousse is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.